MYGN (STOCKS)
Myriad Genetics Inc
$4.590000
+0.240000 (+5.52%)
Prev close: $4.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Samraat S Raha
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $429.20M
- Employees
- 2,700
- P/E (TTM)
- -1.16
- P/B (TTM)
- 1.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
3
Buy
9
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.04 | $-0.01 | +0.0549 | +368.46% |
|
Sep 2025 (Q3)
|
$0.00 | $-0.01 | +0.0080 | +100.00% |
|
Jun 2025 (Q2)
|
$0.05 | $-0.01 | +0.0595 | +626.32% |
|
Mar 2025 (Q1)
|
$-0.03 | $-0.06 | +0.0298 | +49.83% |
Financial Statements
| Revenues | $824.50M |
| Benefits Costs and Expenses | $1.22B |
| Cost Of Revenue | $247.90M |
| Costs And Expenses | $1.22B |
| Gross Profit | $576.60M |
| Nonoperating Income/Loss | -$7.90M |
| Operating Expenses | $963.80M |
| Depreciation and Amortization | $53.70M |
| Research and Development | $106.80M |
| Other Operating Expenses | $803.30M |
| Operating Income/Loss | -$387.20M |
| Income/Loss From Continuing Operations After Tax | -$365.90M |
| Income/Loss From Continuing Operations Before Tax | -$395.10M |
| Income Tax Expense/Benefit | -$29.20M |
| Income Tax Expense/Benefit, Current | -$30.60M |
| Income Tax Expense/Benefit, Deferred | $1.40M |
| Net Income/Loss | -$365.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$365.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$365.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.95 |
| Diluted Earnings Per Share | -$3.95 |
| Basic Average Shares | 92,600,000 |
| Diluted Average Shares | 92,600,000 |
| Assets | $706.60M |
| Current Assets | $332.60M |
| Inventory | $30.60M |
| Other Current Assets | $302.00M |
| Noncurrent Assets | $374.00M |
| Fixed Assets | $114.00M |
| Intangible Assets | $153.40M |
| Other Non-current Assets | $106.60M |
| Liabilities | $338.60M |
| Current Liabilities | $133.80M |
| Accounts Payable | $30.00M |
| Wages | $51.20M |
| Other Current Liabilities | $52.60M |
| Noncurrent Liabilities | $204.80M |
| Long-term Debt | $119.90M |
| Other Non-current Liabilities | $84.90M |
| Equity | $368.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $368.00M |
| Liabilities And Equity | $706.60M |
| Net Cash Flow From Operating Activities | $1.80M |
| Net Cash Flow From Operating Activities, Continuing | $1.80M |
| Net Cash Flow From Investing Activities | -$27.40M |
| Net Cash Flow From Investing Activities, Continuing | -$27.40M |
| Net Cash Flow From Financing Activities | $64.20M |
| Net Cash Flow From Financing Activities, Continuing | $64.20M |
| Exchange Gains/Losses | $800.00K |
| Net Cash Flow | $39.40M |
| Net Cash Flow, Continuing | $38.60M |
| Comprehensive Income/Loss | -$364.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$364.30M |
| Other Comprehensive Income/Loss | -$364.30M |
| Other Comprehensive Income/Loss Attributable To Parent | $1.60M |